Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Completed Phase 2 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0029847 (Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00939627Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent CetuximabTreatment